The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) is set to discuss Covid vaccine injuries in an upcoming meeting. This marks a notable agenda shift under the leadership of new Health Secretary Robert F. Kennedy Jr., who appointed the entire panel last year and replaced all previous members.
Kennedy’s appointees include several vaccine skeptics, stirring debate about the direction of federal vaccine policy. The CDC’s Federal Register notice indicates the panel may also vote on new recommendations related to Covid vaccines during the session.
Despite widespread scientific consensus affirming the safety and effectiveness of Covid vaccines, some committee members have raised concerns over vaccine harms. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, criticized these claims as unsupported or misrepresentative of vetted data.
Osterholm emphasized the need for transparency and rigor if the committee revisits vaccine safety issues. He noted that due to previous misstatements, public trust in the panel’s pronouncements should not be presumed.
Since Kennedy’s appointment, government officials have tightened Covid vaccine guidelines and expressed increased scrutiny on mRNA technology used in Pfizer and Moderna vaccines. Kennedy has controversially labeled the Covid vaccine “the deadliest vaccine ever made,” a claim widely disputed by health experts.
The CDC recently narrowed its vaccine recommendations to suggest Covid shots primarily for adults 65 and older, following consultation with a healthcare provider. This contrasts with earlier guidance endorsing vaccination for everyone aged six months and older.
Further controversies emerged when the FDA’s vaccine chief, Dr. Vinay Prasad, revealed in an internal memo that an agency review linked at least 10 pediatric deaths to Covid vaccination. However, these findings have yet to be publicly disclosed or published in peer-reviewed journals.
The FDA’s regulation of mRNA vaccines has also been inconsistent, exemplified by initially rejecting then later reconsidering Moderna’s mRNA flu vaccine application. The Department of Health and Human Services declined to comment on these developments.
Vaccine policy expert Dorit Reiss from the University of California Law San Francisco highlighted that investigating vaccine injuries is not typically a primary focus for ACIP. She explained the committee usually weighs vaccine risks within the broader context of making immunization recommendations, rather than directly investigating injuries.
Historically, ACIP has addressed vaccine-related risks, such as the myocarditis cases reported mostly in adolescent males following mRNA Covid vaccination in 2021. The panel considered adjusting the dosing schedule in response to these concerns.
Reiss anticipates two possible outcomes from the upcoming meeting: the panel may narrow Covid vaccine recommendations further or propose labeling changes to emphasize potential risks. Typically, vaccine label modifications fall under the FDA’s authority rather than ACIP’s.
In a significant move of dissent, the American College of Obstetricians and Gynecologists withdrew as a liaison member of ACIP. The group cited recent procedural changes under Kennedy that they believe compromise the committee’s commitment to scientific integrity and evidence-based policymaking.
Besides vaccine injuries, the ACIP agenda also includes discussions on long Covid and the methodology used for forming vaccine recommendations. These topics reflect ongoing efforts to adapt public health guidance in a rapidly evolving pandemic landscape.
This upcoming ACIP meeting under Kennedy’s leadership represents a critical moment for U.S. vaccine policy, potentially reshaping official stances on Covid vaccine safety and administration. Stakeholders across public health and medical communities await the outcomes with considerable attention.
Read more at: www.nbcnews.com
